Literature DB >> 6715704

Enhancement of salvage of reperfused myocardium by early beta-adrenergic blockade (timolol).

H Hammerman, R A Kloner, L L Briggs, E Braunwald.   

Abstract

Although reperfusion of severely ischemic myocardium with thrombolytic agents or surgery has shown reduction in infarct size, the time after coronary occlusion during which reperfusion can salvage ischemic myocardium is limited. To determine whether beta-adrenergic blockade could enhance the salvage of ischemic myocardium by reperfusion, the left anterior descending coronary artery was occluded in 18 anesthetized dogs. An in vivo area at risk was determined by injecting technetium-99m-labeled albumin microspheres into the left atrium 5 minutes after occlusion and carrying out radioautography to define the poorly perfused tissue. Fifteen minutes after coronary occlusion, the dogs were randomized either to a control (saline-treated) group (n = 8) or to a timolol-treated group (n = 10). Timolol was administered until a decrease of 20% in heart rate or blood pressure occurred (mean total dose = 0.85 +/- 0.22 mg/kg +/- standard error of the mean). Coronary occlusion was maintained for 3 hours and was followed by 3 hours of reperfusion in both groups. At the end of 6 hours, infarct size was defined by triphenyltetrazolium chloride staining and masses of infarct and risk were calculated. Percent left ventricular mass at risk was similar for both groups (control = 20.9 +/- 2.4%, timolol-treated = 23.7 +/- 2.1%, p = not significant). Mass of necrosis/mass at risk was significantly smaller in the timolol-treated reperfusion group (27.3 +/- 2.7%) versus saline reperfusion alone (46.5 +/- 5.6%) (p less than 0.005). Thus, beta-adrenergic blockade administered early after coronary occlusion results in substantial enhancement of the salvage achieved by reperfusion alone.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6715704     DOI: 10.1016/s0735-1097(84)80282-x

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  9 in total

1.  Determinants of infarct size in non-human primates.

Authors:  W Flameng; E Lesaffre; J Vanhaecke
Journal:  Basic Res Cardiol       Date:  1990 Jul-Aug       Impact factor: 17.165

Review 2.  The role of beta-receptor and calcium-entry-blocking agents in acute myocardial infarction in the thrombolytic era: can the results of thrombolytic reperfusion be enhanced?

Authors:  C J Lavie; J G Murphy; B J Gersh
Journal:  Cardiovasc Drugs Ther       Date:  1988-12       Impact factor: 3.727

3.  Comparison of the effects of acute and chronic beta-blockade on infarct size in the dog after circumflex occlusion.

Authors:  D E Euler; P J Hughes; P J Scanlon
Journal:  Cardiovasc Drugs Ther       Date:  1988-07       Impact factor: 3.727

Review 4.  Congestive heart failure. New frontiers.

Authors:  W W Parmley; K Chatterjee; G S Francis; B G Firth; R A Kloner
Journal:  West J Med       Date:  1991-04

5.  Myocardial reperfusion: a double-edged sword?

Authors:  E Braunwald; R A Kloner
Journal:  J Clin Invest       Date:  1985-11       Impact factor: 14.808

Review 6.  Recent clinical developments in thrombolysis in acute myocardial infarction.

Authors:  J L Anderson
Journal:  Drugs       Date:  1987       Impact factor: 9.546

7.  Cardioprotection by early metoprolol- attenuation of ischemic vs. reperfusion injury?

Authors:  Petra Kleinbongard
Journal:  Basic Res Cardiol       Date:  2020-08-03       Impact factor: 17.165

8.  Effects of oral pretreatment with metoprolol on left ventricular wall motion, infarct size, hemodynamics, and regional myocardial blood flow in anesthetized dogs during thrombotic coronary artery occlusion and reperfusion.

Authors:  K Zmudka; J Dubiel; J Vanhaecke; W Flameng; H De Geest
Journal:  Cardiovasc Drugs Ther       Date:  1994-06       Impact factor: 3.727

9.  Efficacy of a Novel Mitochondrial-Derived Peptide in a Porcine Model of Myocardial Ischemia/Reperfusion Injury.

Authors:  Thomas E Sharp; Zhenwei Gong; Amy Scarborough; Eric S Goetzman; Murtuza J Ali; Pablo Spaletra; David J Lefer; Radhika H Muzumdar; Traci T Goodchild
Journal:  JACC Basic Transl Sci       Date:  2020-06-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.